Dawes/Fretzin Dermatology Group Inc

Indianapolis, Indiana 46256

0 studies enrolling now · 3 studies all time

What they study most

Plaque-type Psoriasis, Psoriasis

Studies at this site

• A Long-term Extension Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis — Completed
• Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis — Completed
• Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study) — Completed